Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.55 +0.62 (+1.77%)
Streaming Delayed Price Updated: 9:34 AM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 205,326
Open 35.37
Bid (Size) 35.42 (1)
Ask (Size) 35.54 (5)
Prev. Close 34.93
Today's Range 35.19 - 35.60
52wk Range 18.92 - 81.73
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Viking Therapeutics: High Risk, High Reward Play
Via MarketBeat
Here's Why This Obesity Drug Company's Share Price Soared Today
The company had positive updates on its clinical trials. 
Via The Motley Fool
Topics Earnings

Performance

YTD
-13.5%
-13.5%
1 Month
+37.7%
+37.7%
3 Month
+8.0%
+8.0%
6 Month
+27.2%
+27.2%
1 Year
-52.3%
-52.3%

More News

Read More
Why Is Viking Therapeutics Stock Rising Today?
Via Benzinga
Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside
Via Stocktwits
Topics Artificial Intelligence
Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies
Via Investor's Business Daily
Earnings Preview For Viking Therapeutics
Via Benzinga
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
Via Stocktwits
Viking Therapeutics (NASDAQ:VKTX) Reports Q3 2025 Earnings Miss and 2.8% After-Hours Decline
Via Chartmill
Topics Earnings
Retail Investors' Top Stocks With Earnings This Week: Tesla, Netflix, Intel and More
Via Benzinga
These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond
Via The Motley Fool
Earnings Scheduled For October 22, 2025
Via Benzinga
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?
Via The Motley Fool
Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly?
Via The Motley Fool
Down 44%, Should You Buy the Dip on Viking Therapeutics?
Via The Motley Fool
4 Healthcare Stocks to Buy Now
Via The Motley Fool
Topics Artificial Intelligence
Why Shares in Viking Therapeutics Surged This Week
Via The Motley Fool
The Best Stocks to Invest $1,000 in Right Now
Via The Motley Fool
Topics Artificial Intelligence
Why This Beaten-Down GLP-1 Stock Could Be a Steal
Via The Motley Fool
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.
Via The Motley Fool
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’
Via Stocktwits
Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
Via MarketMinute
Topics Economy Intellectual Property
6 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months
Via The Motley Fool
Topics Bankruptcy
Biotech Breakouts: 3 Stocks With Massive Upside Potential
Via MarketBeat
Novo Nordisk Faces Headwinds: Competitive Pressures and Compounded Drugs Force Lowered Outlook
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 35.55
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 10/29/25 09:34 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.54B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.